Arrowstreet Capital, Limited Partnership Grifols Sa Transaction History

Arrowstreet Capital, Limited Partnership

$148 Billion
Q3 2025

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Grifols Sa stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 2,800,645 shares of GRFS stock, worth $24.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,800,645

Previous 579,012 383.69%

Holding current value

$24.4 Million

Previous $5.23 Million 432.94%

% of portfolio

0.02%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$8.87 - $10.85 $19.7 Million - $24.1 Million	2,221,633 Added 383.69%	2,800,645 $27.9 Million
Q2 2025 Aug 13, 2025	SELL	$6.49 - $9.09 $584,710 - $818,954	-90,094 Reduced 13.46%	579,012 $5.23 Million
Q1 2025 May 14, 2025	BUY	$6.62 - $8.71 $2.02 Million - $2.66 Million	305,173 Added 83.85%	669,106 $4.76 Million
Q4 2024 Feb 12, 2025	SELL	$6.99 - $9.55 $590,675 - $807,003	-84,503 Reduced 18.84%	363,933 $2.71 Million
Q3 2024 Nov 14, 2024	BUY	$6.28 - $9.38 $1.91 Million - $2.86 Million	304,725 Added 212.04%	448,436 $3.98 Million

Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $1.45 Million - $1.78 Million	-231,518 Reduced 61.7%	143,711 $906,000
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $1.62 Million - $3.38 Million	296,725 Added 377.97%	375,229 $2.51 Million
Q4 2023 Feb 14, 2024	BUY	$7.71 - $11.56 $605,265 - $907,506	78,504 New	78,504 $908,000
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $14.6 Million - $18.4 Million	-1,381,858 Reduced 83.71%	268,812 $3.19 Million
Q1 2022 May 13, 2022	SELL	$10.37 - $12.73 $4.75 Million - $5.83 Million	-457,983 Reduced 21.72%	1,650,670 $19.3 Million
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $1.34 Million - $2.01 Million	-131,678 Reduced 5.88%	2,108,653 $23.7 Million
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $25.8 Million - $31.7 Million	1,831,499 Added 447.98%	2,240,331 $32.7 Million
Q2 2021 Aug 13, 2021	SELL	$16.62 - $18.94 $3.01 Million - $3.43 Million	-181,328 Reduced 30.73%	408,832 $7.09 Million
Q1 2021 May 14, 2021	SELL	$15.15 - $19.78 $1.73 Million - $2.25 Million	-114,002 Reduced 16.19%	590,160 $10.2 Million
Q4 2020 Feb 12, 2021	SELL	$16.86 - $19.67 $6.97 Million - $8.14 Million	-413,634 Reduced 37.0%	704,162 $13 Million
Q3 2020 Nov 12, 2020	BUY	$15.4 - $20.16 $3.45 Million - $4.52 Million	224,126 Added 25.08%	1,117,796 $19.4 Million
Q2 2020 Aug 12, 2020	BUY	$18.24 - $21.45 $4.91 Million - $5.78 Million	269,458 Added 43.17%	893,670 $16.3 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $13.8 Million - $21.7 Million	-844,964 Reduced 57.51%	624,212 $12.6 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $13.8 Million - $16.6 Million	705,379 Added 92.35%	1,469,176 $34.2 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $15.2 Million - $17.4 Million	763,797 New	763,797 $15.3 Million
Q2 2019 Aug 14, 2019	SELL	$17.59 - $21.1 $27.6 Million - $33.1 Million	-1,570,281 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$18.01 - $20.11 $24.6 Million - $27.5 Million	-1,365,540 Reduced 46.51%	1,570,281 $31.6 Million
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $3.31 Million - $4.09 Million	-189,858 Reduced 6.07%	2,935,821 $53.9 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $48.9 Million - $53.7 Million	2,447,574 Added 360.94%	3,125,679 $66.8 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $13.7 Million - $16.7 Million	678,105 New	678,105 $14.6 Million
Q1 2018 May 14, 2018	SELL	$20.31 - $24.95 $3.32 Million - $4.08 Million	-163,622 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$20.99 - $23.89 $2.48 Million - $2.82 Million	-118,165 Reduced 41.93%	163,622 $3.75 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $5.66 Million - $6.17 Million	281,787	281,787 $6.17 Million

Others Institutions Holding GRFS

# of Institutions

200

Shares Held

148M

Call Options Held

76.1K

Put Options Held

58.2K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Grifols Sa Transaction History